Rasagiline mesylate
- Product NDC
- 71921-407
- 11-digit product format
- 719210407
- Labeler code
- 71921
- Product ID
- 71921-407_3b57a1c9-0ad9-40cf-a972-29851a658489
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Rasagiline mesylate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Florida Pharmaceutical Products, LLC
- Application
- ANDA206153
- Marketing category
- ANDA
- Marketing start
- 2026-04-14
- Substance
- RASAGILINE MESYLATE
- Active strength
- .5 mg/1
- Pharmacologic classes
- Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Rasagiline mesylate
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| RASAGILINE MESYLATE | .5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | LH8C2JI290 |
| Rxcui | 608328, 636664 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 71921-407-33 | Rasagiline mesylate | 30 in 1 BOTTLE | TABLET | 30 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 71921-407-33 | 71921040733 | 30 TABLET in 1 BOTTLE (71921-407-33) | 30 tablet | 2026-04-14 | No | No | Historical |